Search

everythinglearnresearchcommunity

for

Search:↓

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Erbium YAG laser treatment, combined with conventional therapy, can effectively reduce hair loss and promote hair growth in men with androgenetic alopecia.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

A woman's hair loss was caused by her husband's testosterone gel and a diabetic man's nail disease led to bone infection, both treated successfully.

Testosterone improves mood and thinking skills; finasteride has no effect.

Microneedle therapy combined with serum effectively increases hair count in people with hair loss, with no side effects.

Microneedling combined with other treatments significantly improves hair growth in people with hair loss and is safe.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Minoxidil helps regrow hair in female pattern hair loss, but more research needed for other treatments.

The microneedle device with rapamycin and epigallocatechin gallate effectively promoted hair regrowth in mice.

New skin disease treatments using TDDS are improving but face challenges like side effects and high costs.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

The microneedle patch with quercetin, zinc, and copper effectively promotes hair regrowth for androgenic alopecia.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Finasteride and minoxidil work best together for hair loss.